Inventor · disambiguated record
Minna Bui
Also filed as: BUI MINNA · BUI MINNA H T · BUI MINNA HUE THANH
18 granted patents·10 pending applications·84 citations·filing 2010–2023
93Inventor score
Top patents by PatentIndex Score
28 records- 0192US9790229B2Bruton's tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Granted Oct 17, 2017·11 cites·21 claims
- 0291US10246462B2Chemokine receptor modulators and uses thereofFLX BIO INC·Filed 2017·Granted Apr 2, 2019·10 cites·77 claims
- 0391US8785440B2Bruton's tyrosine kinase inhibitorsBUI MINNA·Filed 2010·Granted Jul 22, 2014·20 cites·20 claims
- 0490US10179787B2Chemokine receptor modulators and uses thereofFLX BIO INC·Filed 2017·Granted Jan 15, 2019·5 cites·38 claims
- 0589US9249146B2Bruton'S tyrosine kinase inhibitorsBIOGEN IDEC INC·Filed 2014·Granted Feb 2, 2016·9 cites·25 claims
- 0687US10604526B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2018·Granted Mar 31, 2020·2 cites·25 claims
- 0784US11542259B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2019·Granted Jan 3, 2023·3 cites·2 claims
- 0884US9029359B2Heteroaryl Btk inhibitorsBUI MINNA·Filed 2010·Granted May 12, 2015·12 cites·18 claims
- 0984US2024246988A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1083US11708367B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2019·Granted Jul 25, 2023·2 cites·20 claims
- 1182US10577374B2Bruton's tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2017·Granted Mar 3, 2020·2 cites·18 claims
- 1282US8716290B2Heterocyclic compounds and their usesAMGEN INC·Filed 2013·Granted May 6, 2014·5 cites·15 claims
- 1381US11046699B2Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic usesRAPT THERAPEUTICS INC·Filed 2019·Granted Jun 29, 2021·3 cites·46 claims
- 1481US2024199620A1Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1578US2023046457A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1675US12195475B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2023·Granted Jan 14, 2025·0 cites·12 claims
- 1772US2024150371A1Compounds for the Treatment of Kinase-Dependent DisordersEXELIXIS INC·Filed 2023·Application pending·0 cites
- 1870US2024043414A1Compounds for the Treatment of Kinase-Dependent DisordersEXELIXIS INC·Filed 2022·Application pending·0 cites
- 1970US2020399283A1Bruton's tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2066US2020239480A1Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2162US11673897B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2019·Granted Jun 13, 2023·0 cites·14 claims
- 2253US12503438B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2020·Granted Dec 23, 2025·0 cites·10 claims
- 2353US8835432B2Heterocyclic compounds and their usesAMGEN INC·Filed 2014·Granted Sep 16, 2014·0 cites·8 claims
- 2448US2021317134A1Ubiquitin-specific-processing protease 7 (usp7) modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2547US12371428B2Pyridone compounds and methods of useEXELIXIS INC·Filed 2020·Granted Jul 29, 2025·0 cites·27 claims
- 2646US9873704B2Heterocyclic compounds and their usesAMGEN INC·Filed 2016·Granted Jan 23, 2018·0 cites·3 claims
- 2743US2010331306A1Heterocyclic compounds and their usesAMGEN INC·Filed 2010·Application pending·0 cites
- 2835US2013085131A1Heterocyclic compounds and their usesBUI MINNA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Minna Bui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →